APA (7th ed.) Citation

Jiang, V., Lee, W., Zhang, T., Jordan, A., Yan, F., Cai, Q., . . . Wang, M. (2024). The CDK9 inhibitor enitociclib overcomes resistance to BTK inhibition and CAR-T therapy in mantle cell lymphoma. Biomarker Research, 12(1), . https://doi.org/10.1186/s40364-024-00589-7

Chicago Style (17th ed.) Citation

Jiang, Vivian, et al. "The CDK9 Inhibitor Enitociclib Overcomes Resistance to BTK Inhibition and CAR-T Therapy in Mantle Cell Lymphoma." Biomarker Research 12, no. 1 (2024). https://doi.org/10.1186/s40364-024-00589-7.

MLA (9th ed.) Citation

Jiang, Vivian, et al. "The CDK9 Inhibitor Enitociclib Overcomes Resistance to BTK Inhibition and CAR-T Therapy in Mantle Cell Lymphoma." Biomarker Research, vol. 12, no. 1, 2024, https://doi.org/10.1186/s40364-024-00589-7.